Slashing US drug prices would come at a cost

In many cases, the market charges (https://www.breakingviews.com/columns/breaking-view/big-pharma-prevails-art-drug-deal-2025-10-01/) nearly triple what others do, a discrepancy (https://www.reuters.com/commentary/breakingviews/obesity-kings-buffet-is-slimmer-than-it-looks-2025-10-02/) that has put President Trump on the warpath (https://www.reuters.com/commentary/breakingviews/big-pharmas-tariff-win-leaves-lingering-aches-2025-09-26/) . In this Viewsroom podcast, Breakingviews columnists discuss how Americans subsidize novel treatments and how tricky it will be to spread the burden. Visit the Thomson Reuters Privacy Statement (https://www.thomsonreuters.com/en/privacy-statement.html) for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices (https://megaphone.spotify.com/about-advertisements) to opt-out of targeted advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices (https://megaphone.fm/adchoices)